Navigation Links
Clinical Research Coordinator From PMG Research of Bristol Wins 3rd Place in US Clinical Researcher of the Year Competition

(PRWEB) November 14, 2013

PharmaTimes, a global pharmaceutical media and news organization, held its fifth annual US Clinical Researcher of the Year competition at the SAS Institute in Cary, NC. The competition is a competency-based three-phase process consisting of a multiple choice test, essay, interviews and a presentation to a panel of more than 30 industry expert judges. Chasity Monk, Clinical Research Coordinator (CRC) at PMG Research of Bristol, won the third place Pharma Bronze Award. This marks the second consecutive year in which a PMG Research CRC has placed in the Study Nurse/Clinical Research Coordinator category.

Although the competition brought together and recognized some of the best talent in the clinical research community, it was also a meaningful personal and professional learning experience for participants. According to Monk, “Competing in the final round of the Pharma Times Clinical Researcher of the Year Competition was an amazing experience. I was honored to be one of six people competing for the title, and winning the Pharma Bronze Award was more than I ever anticipated. It was such a privilege to represent PMG Research on a national level, and it's something I will never forget.”

The competition offers clinical researchers in the United States the opportunity to benchmark their skills against their peers in a variety of categories. It recognizes both new and experienced professionals from the clinical research community in various categories: Study Nurse/Clinical Research Coordinator, New Clinical Research Associate (CRA), Experienced CRA, Project Manager, Study Leader, and Clinical Team. Winners were announced on November 7th at the awards ceremony in Cary, NC.

“Making it to the finals not only gave me the chance to compete with my peers, but it also provided me with the opportunity to meet and collaborate with members of the research community from all across the United States,” explains Monk. “I am extremely dedicated to my career in research, and I wake up every morning knowing I have a career that I love. To me this feeling is priceless, and receiving recognition for my hard work and dedication is simply a bonus!”


About PMG Research, Inc.
PMG Research, Inc. is an Integrated Site Network (ISN) of clinical research facilities in the southeast region of the United States with locations in Cary, Charlotte, Hickory, Raleigh, Salisbury, Wilmington, and Winston-Salem, NC; Bristol and Knoxville, TN; and Charleston, SC. We have extensive experience conducting all phases of trials across a comprehensive list of conditions. Since 1979, PMG has conducted 6,800 research studies for more than 100 pharmaceutical sponsors and CROs. Our progressive organization is comprised of a team of highly effective professionals and a network of specially-designed sites. Our mission is to bring clinical research to as many lives as possible while delivering unparalleled service and exceptional value to our clinical trial partners and stakeholders. For more information about PMG Research please visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
2. Positive Clinical Study Results for BSPs HyperQ Technology
3. DermTechs Non-invasive Melanoma Detection Assay Poised to Enter Clinical Validation Study
4. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
5. AtheroNova Inc. Preclinical Study Demonstrates 95% Reduction in Arterial Plaque Formation
6. A New Type of Dendritic Cell-Based Cancer Vaccine has Received Approval for Clinical Tests and at the Same Time Secures Substantial Financing
7. Generex Provides Update on Generex Oral-lyn™ Clinical & Regulatory Program
8. US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium
9. TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML)
10. Echo Therapeutics Announces Positive Results of Clinical Trial of its Symphony® Transdermal Continuous Glucose Monitoring (tCGM) System in Patients With Type 1 and Type 2 Diabetes
11. Leading Investigator to Present Clinical Data on Generex Oral-lyn™ at International Diabetes Federation Meetings in Dubai
Post Your Comments:
(Date:10/17/2019)... Conn. (PRWEB) , ... October 16, 2019 , ... ... that provides personalized, easy-to-understand, web-based genetic counseling information, has published a new white ... five year period and provides guidance as to how patients and medical providers ...
(Date:10/10/2019)... , ... October 09, 2019 , ... ... Abernethy, MD, PhD, Principal Deputy Commissioner, FDA, as a newly-confirmed keynote speaker for ... 2019 in Las Vegas, Nevada USA. , Dr. Abernethy, a hematologist/oncologist and palliative ...
(Date:10/10/2019)... ... October 10, 2019 , ... R3 Stem Cell announces it has added ... 18-19th, 2019 in Las Vegas with spots still open. , The speaker, Dr. Ian ... Ivy League universities including Cornell, Harvard and Dartmouth. He currently serves as the Chief ...
(Date:10/8/2019)... ... October 08, 2019 , ... As Keck Graduate Institute ... presented company executives with a set of recommendations to enhance supply chain processes. ... from their TMP to a wider audience of industry leaders attending the 12th ...
Breaking Biology Technology:
(Date:10/8/2019)... ... October 07, 2019 , ... Imaging data sets are generated ... optical projection tomography, optical coherence tomography, echocardiogram, light sheet microscopy, MRI and X-ray ... inhouse, a lot of research groups struggle with transforming these large and sometimes ...
(Date:10/4/2019)... ... October 04, 2019 , ... Representatives with MyBioGate ( ... the Grand Elysée Hamburg Rothenbaumchaussee in Hamburg. , “To better connect Chinese companies ... Guo, Vice President of Operations and spokesperson for MyBioGate. , Guo went on ...
(Date:10/3/2019)... FORT WORTH, Texas (PRWEB) , ... October 01, ... ... to support the aseptic pouring and dispensing of chemicals, reagents, and medias and ... “The second generation CHEM+POUR Bag is the culmination of years of experience and ...
Breaking Biology News(10 mins):